{
  "study_metadata": {
    "design": "RCT|randomized|double-blind|placebo-controlled",
    "species": "Homo sapiens",
    "n_total": 45,
    "country": "Iran",
    "setting": "outpatient",
    "population": "type 2 diabetes patients",
    "inclusion_key": "HbA1c ≥7, age 30-70, BMI<35, on diet/hypoglycemic agents other than insulin",
    "exclusion_key": "type 1 diabetes, pregnancy, lactation, antioxidant, insulin, anticoagulants, steroids, anti-inflammatory drugs, severe heart disease, hepatic or kidney disease, complications, unstable weight",
    "mean_age": null,
    "female_pct": null,
    "diabetes_status": "T2D",
    "primary_outcome": "FPG"
  },
  "intervention": {
    "agent": "resveratrol",
    "form": "capsule",
    "dose_mg_per_day": 800,
    "duration_weeks": 8,
    "cointerventions": "diet and/or hypoglycemic agents"
  },
  "comparison": {
    "type": "placebo",
    "description": "identical placebo capsules"
  },
  "arms": [
    {
      "name": "resveratrol",
      "n": 22,
      "dose_mg_per_day": 800,
      "duration_weeks": 8
    },
    {
      "name": "placebo",
      "n": 23,
      "dose_mg_per_day": 0,
      "duration_weeks": 8
    }
  ],
  "outcomes_raw": [
    {
      "name": "FPG",
      "timepoint_weeks": 8,
      "arm_name": "resveratrol",
      "baseline_mean": null,
      "baseline_sd": null,
      "followup_mean": null,
      "followup_sd": null,
      "change_mean": null,
      "change_sd": null,
      "units": "mg_dL",
      "notes": "significant reduction in fasting blood glucose"
    }
  ],
  "effects_by_outcome": [
    {
      "name": "FPG",
      "type": "MD",
      "timepoint_weeks": 8,
      "estimate": null,
      "ci_low": null,
      "ci_high": null,
      "p_value": null,
      "adjusted": "false",
      "model_notes": null
    }
  ],
  "risk_of_bias": {
    "randomization_process": "some_concerns",
    "deviations_from_intended": "some_concerns",
    "missing_outcome_data": "some_concerns",
    "measurement_of_outcome": "some_concerns",
    "selection_of_reported_result": "some_concerns",
    "overall": "some_concerns"
  },
  "effect": {
    "type": null,
    "estimate": null,
    "ci_low": null,
    "ci_high": null,
    "p_value": null
  },
  "where_found": [
    {
      "section": "abstract",
      "page": 3
    },
    {
      "section": "methods",
      "page": 6
    }
  ],
  "evidence": [
    {
      "section": "abstract",
      "page": 3,
      "snippet": "A total of 45 T2D patients were supplemented with either of 800 mg/day resveratrol or placebo capsules for eight weeks."
    },
    {
      "section": "abstract",
      "page": 3,
      "snippet": "we did not find any significant change in the metabolic and anthropometric parameters except for a significant reduction in fasting blood glucose and blood pressure."
    }
  ],
  "missing_fields": [
    "study_metadata.mean_age",
    "study_metadata.female_pct",
    "study_metadata.inclusion_key",
    "study_metadata.exclusion_key",
    "outcomes_raw.baseline_mean",
    "outcomes_raw.baseline_sd",
    "outcomes_raw.followup_mean",
    "outcomes_raw.followup_sd",
    "outcomes_raw.change_mean",
    "outcomes_raw.change_sd",
    "effects_by_outcome.estimate",
    "effects_by_outcome.ci_low",
    "effects_by_outcome.ci_high",
    "effects_by_outcome.p_value"
  ],
  "confidence": 0.4,
  "comment": "Limited numeric data; only qualitative effect reported.",
  "comment_detailed": "I searched the abstract, methods, and results sections for numeric outcomes on fasting blood glucose. The study reports a significant reduction but does not provide means, SDs, or effect sizes. Therefore, baseline and follow‑up values, change statistics, and confidence intervals are unknown. I also noted the study design, population, intervention dose, and comparator. Missing numeric data prevent calculation of an effect estimate. Full tables or supplementary material would provide the necessary statistics."
}